Weighted Average Number of Shares Outstanding, Diluted of Protalix BioTherapeutics, Inc. from 30 Jun 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Protalix BioTherapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2011 to 31 Dec 2025.
  • Protalix BioTherapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 78,546,234, a 3.1% decline year-over-year.
  • Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 78,546,234, a 3.1% decline from 2024.
  • Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 81,057,176, a 1.7% decline from 2023.
  • Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 82,424,016, a 70% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Protalix BioTherapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 78,546,234 -2,510,942 -3.1% 01 Oct 2025 31 Dec 2025 10-K 18 Mar 2026 2025 FY
Q3 2025 80,814,564 -402,504 -0.5% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 81,271,610 +7,963,329 +11% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 76,611,980 +3,575,411 +4.9% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 81,057,176 -1,366,840 -1.7% 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2026 2025 FY
Q3 2024 81,217,068 -2,565,611 -3.1% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 73,308,281 -9,892,360 -12% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 73,036,569 +15,556,560 +27% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 82,424,016 +33,951,857 +70% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2026 2025 FY
Q3 2023 83,782,679 +34,284,574 +69% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 83,200,641 +35,872,689 +76% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 57,480,009 +11,636,446 +25% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 48,472,159 +4,331,926 +9.8% 01 Oct 2022 31 Dec 2022 10-K 17 Mar 2025 2024 FY
Q3 2022 49,498,105 +3,941,458 +8.7% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 47,327,952 +1,891,045 +4.2% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 45,843,563 +5,909,591 +15% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 44,140,233 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 45,556,647 +12,692,859 +39% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 45,436,907 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 39,933,972 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q3 2020 32,863,788 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2018 146,644,450 -45,953,939 -24% 01 Apr 2018 30 Jun 2018 10-Q 18 Mar 2019 2018 Q2
Q2 2017 192,598,389 +92,839,878 +93% 01 Apr 2017 30 Jun 2017 10-Q 18 Mar 2019 2018 Q2
Q2 2016 99,758,511 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q2 2013 92,297,522 -2,583,645 -2.7% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q2 2012 94,881,167 +9,301,633 +11% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013 2013 Q2
Q2 2011 85,579,534 01 Apr 2011 30 Jun 2011 10-Q 03 Aug 2012 2012 Q2

Protalix BioTherapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 78,546,234 -2,510,942 -3.1% 01 Jan 2025 31 Dec 2025 10-K 18 Mar 2026 2025 FY
2024 81,057,176 -1,366,840 -1.7% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2026 2025 FY
2023 82,424,016 +33,951,857 +70% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2026 2025 FY
2022 48,472,159 +4,331,926 +9.8% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025 2024 FY
2021 44,140,233 +14,992,186 +51% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 29,148,047 +14,309,834 +96% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 14,838,213 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.